Joint Pain News and Research

RSS

Nabilone marijuana-based drug reduces fibromyalgia pain

Patients with fibromyalgia treated with a synthetic form of marijuana, nabilone, showed significant reductions in pain and anxiety in a first-of-its-kind study, published in The Journal of Pain.

17 Feb 2008

Untreated blood disorder leads to liver cancer and arthritis

Australian researchers have discovered that more than one quarter of men with hemochromatosis develop liver cancer, arthritis and other complications.

20 Jan 2008

Lymphangioleiomyomatosis - potential clues into the treatment and diagnosis

Studies published in the Jan. 10 edition of the New England Journal of Medicine (NEJM) are providing clues into the treatment and diagnosis of LAM, or lymphangioleiomyomatosis, a progressive and deadly lung disease that affects women in their childbearing years.

11 Jan 2008

The drug sirolimus shrinks tumors, improves lung function

The drug sirolimus, normally used to help transplant patients fight organ rejection, may eventually be used as a less invasive treatment for a tumor called angiomyolipomata in patients with who would otherwise face surgery.

10 Jan 2008

Combining medications often best strategy to battle rheumatoid arthritis

For patients with rheumatoid arthritis, combining one well-known, lower cost synthetic drug with one of six biologic medications often works best to reduce joint swelling or tenderness, according to a new report funded by the Agency for Healthcare Research and Quality, part of the U.S. Department of Health and Human Services.

18 Dec 2007

Chikungunya in La Reunion - new findings

Researchers have discovered the key to how a mysterious mosquito-borne viral outbreak swept over the Indian Ocean island of La Reunion in 2005 and 2006, infecting about 266,000 people and causing at least 260 deaths — the first fatalities to be reported in connection with the virus, known as chikungunya.

10 Dec 2007

Combining medications often best strategy to battle rheumatoid arthritis

For patients with rheumatoid arthritis, combining one well-known, lower-cost synthetic drug with one of six biologic medications often works best to reduce joint swelling or tenderness, according to a new report by researchers at the RTI International-University of North Carolina at Chapel Hill Evidence-based Practice Center, which is sponsored by the Agency for Healthcare Research and Quality.

19 Nov 2007

Optical non-invasive tool to test for decompression sickness

It may not rank among the top 10 causes of death, but decompression sickness can be fatal. Instead of waiting for symptoms to appear, a University of Houston professor is developing a laser-based system that can diagnose the sickness in a matter of seconds.

13 Nov 2007

FDA approves approved Ixempra (ixabepilone) for advanced breast cancer

The U.S. Food and Drug Administration has approved Ixempra (ixabepilone), a new anti-cancer treatment, for use in patients with metastatic or locally advanced breast cancer who have not responded to certain other cancer drugs.

22 Oct 2007

Breakbone fever a growing public health threat

Dengue fever, known as “breakbone fever” because of the excruciating back and joint pain that accompanies this infectious disease, is a growing public health threat for people living in tropical countries, as well as travelers to destinations such as Thailand, Brazil and Puerto Rico, according to research being presented at the annual meeting of the American Society of Tropical Medicine and Hygiene (ASTMH), Nov. 4-7.

17 Oct 2007

Evista (raloxifene hydrochloride) approved for breast cancer

The U.S. Food and Drug Administration today approved Evista (raloxifene hydrochloride) for reducing the risk of invasive breast cancer in postmenopausal women with osteoporosis and in postmenopausal women at high risk for invasive breast cancer.

17 Sep 2007

Some with breast cancer stop taking aromatase inhibitors because of joint and muscle pain

More than 10 percent of women with breast cancer stopped taking a commonly prescribed drug because of joint and muscle pain, according to a new study from researchers at the University of Michigan Comprehensive Cancer Center.

10 Sep 2007

Organ-transplant drug may help fight lupus

A compound related to a drug used in humans to prevent organ-transplant rejection attacks a key biochemical process in the faulty immune cells of lupus-prone mice, suggesting a possible new approach to combating the disease, UT Southwestern Medical Center researchers have found.

17 Aug 2007

Organ-transplant drug may aid in lupus fight

15 Aug 2007

Mother and daughter tackle obesity and diabetes together

Two months ago, Phoenix residents Marlene Zytcer, 57, and her daughter Aimee, 31, traveled to the University of California, San Diego Medical Center for a minimally invasive surgery to lose weight.

7 Aug 2007

Warning on Chikungunya virus

Fever, arthritis, and other symptoms occurring in people to who have recently traveled to islands in the Indian Ocean may signal infection with an imported virus called "chikungunya," reports a study in the May/June issue of the journal Medicine, published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.

9 Jul 2007

Summertime is tick time and Lyme disease is on the rise

The Centers for Disease Control and Prevention (CDC) in the United States says cases of the tick borne illness Lyme disease are on the rise across the country.

18 Jun 2007

Enbrel safety data for up to 8 years in patients with juvenile rheumatoid arthritis

Amgen and Wyeth Pharmaceuticals, a division of Wyeth have announced the presentation of additional data that showed that the safety profile of Enbrel, (etanercept) was maintained with long-term use in patients with moderate-to-severe juvenile rheumatoid arthritis (JRA) who completed up to eight years of therapy.

17 Jun 2007